The Department of Health Policy and Management (HPM) has a rich history of educating individuals for careers in health policy and management since its inception in 1950. Our strengths include the areas of health system governance and management, long-term care, Medicare and Medicaid policy, pharmaceutical policy, mathematical modeling and simulation, and health economics.

We prepare students in our MPH (and JD/MPH) programs to develop and advocate for public policies, create policy regulation, and work in governmental and public health sectors. Our MHA (and MHA-MBA) are prepared to fill key leadership positions in health care systems, hospitals, health insurance firms, consulting firms, physician groups, long-term care, and many other health-related organizations. As successful health care system executives these graduates provide leadership and are skilled in the management, financing and delivery of services, technological innovations, health policy and regulatory requirements, and public health and disease prevention strategies.

Students in our research-focused MS and PHD programs develop the rigorous analytical and quantitative skills needed for careers in top academic settings, government, and industry.

Maximize Find a research program for your interests

Maximize Pursue a career in health policy and management

Maximize HPM Academic Programs

 

Gilead’s Covid drug win could clog pipeline for other treatments

BLOOMBERG LAW - The future of...
Gilead’s Covid drug win could clog pipeline for other treatments

BLOOMBERG LAW - The future of Covid-19 treatment research is cloudier after the FDA approved Gilead Sciences Inc.'s remdesivir. The approval solidifies the standard of care for hospitalized virus patients in the U.S. Shortages of remdesivir could slow down the development of other new Covid-19 drug... (10/27/2020)

Gellad criticizes how Science gets political as Trump touts experimental coronavirus drugs

AXIOS - "We have an emergency...
Gellad criticizes how Science gets political as Trump touts experimental coronavirus drugs

AXIOS - "We have an emergency use authorization that I want to get signed immediately," Trump said in a video Thursday. "The problem is every therapy for coronavirus has become politicized—every single therapy, and that's the last thing you want in a pandemic, so this is just next in line," said th... (10/13/2020)

Roberts says Gov. Wolf’s restrictions saved many lives

PHILADELPHIA TRIBUNE - Nearly...
Roberts says Gov. Wolf’s restrictions saved many lives

PHILADELPHIA TRIBUNE - Nearly 8,000 COVID-19 deaths have been confirmed in Pennsylvania. Had fewer restrictions been imposed, that toll likely would have been several times higher, said Mark Roberts, director of the Public Health Dynamics Lab. “It’s easy to project that there would be two to three ... (09/27/2020)

Hernandez says experimental medicines for COVID-19 could help someday, but home runs not guaranteed

WBHM - This proof-of concept ...
Hernandez says experimental medicines for COVID-19 could help someday, but home runs not guaranteed

WBHM - This proof-of concept study suggests that the strategy of blocking virus with antibodies holds promise. Inmaculada “Inma” Hernandez (HPM ’16), Pitt School of Pharmacy, is hopeful, but she doubts that these drugs will be a game-changer. “These drugs are so complex to produce, probably we will... (09/18/2020)

Jalal research shows fatal overdoses in U.S. rebounded in 2019

TRIBUNE-DEMOCRAT – “We are co...
Jalal research shows fatal overdoses in U.S. rebounded in 2019

TRIBUNE-DEMOCRAT – “We are concerned that policymakers may have interpreted the one-year downturn in 2018 as evidence for an especially effective national response or the start of a long-term trend,” said lead author Hawre Jalal, HPM. “Unfortunately, that isn’t supported by the data.” The data sugg... (09/17/2020)